Second-Generation AURKA-Targeting PROTACs: Structural Optimization toward in Vivo Degradation in Neuroblastoma. [PDF]
Krols S +16 more
europepmc +1 more source
MYCN amplification defines an aggressive phenotype in IDH-mutant gliomas. [PDF]
Xie X +5 more
europepmc +1 more source
Correction: Ruas et al. Somatic Copy Number Alteration in Circulating Tumor DNA for Monitoring of Pediatric Patients with Cancer. <i>Biomedicines</i> 2023, <i>11</i>, 1082. [PDF]
Ruas JS +12 more
europepmc +1 more source
Editorial: Molecular mechanisms and treatment of MYCN-driven tumors, volume II. [PDF]
Zhu Y, Suenaga Y.
europepmc +1 more source
Exploring the prognostic molecular mechanisms of medulloblastoma through methylation-transcriptome integration. [PDF]
Tuerxun K +5 more
europepmc +1 more source
Pharmacological Inhibition of JNK Signalling Exerts Anti-Neoplastic Effects on SH-SY5Y Human Neuroblastoma Cells. [PDF]
Granek Z +6 more
europepmc +1 more source
Human Retinal Organoid Modeling Defines Developmental Window and Therapeutic Vulnerabilities in MYCN-Amplified Retinoblastoma. [PDF]
Park J +12 more
europepmc +1 more source
Significance of ARID1A in neuroblastoma onset mechanism. [PDF]
Jin D, Zhang D, Tang Q.
europepmc +1 more source

